Cerebras, Mega-Funds, and the $10 Billion Secondary Market: How 2026 Is Reshaping Pre-IPO Access

Three data points in the span of two weeks tell you everything about where pre-IPO markets are heading. AI chipmaker Cerebras Systems tapped Morgan Stanley to lead an IPO that could raise $2 billion as soon as April. Venture firms including General Catalyst, Founders Fund, and Andreessen Horowitz collectively announced over $34 billion in new fund commitments. And cumulative secondary trading volume for late-stage private companies crossed the $10 billion threshold in 2025, a record that 2026 is already on pace to break.

These are not isolated events. They represent a structural shift in how capital forms, moves, and finds liquidity in private markets. Understanding the mechanics behind each of these forces is essential for anyone studying pre-IPO dynamics.

Cerebras and the New IPO Playbook

Cerebras Systems, which designs wafer-scale AI training chips, has had one of the more instructive pre-IPO journeys in recent memory. The company filed its original S-1 in late 2024, pulled the offering in October 2025 after completing a $1.1 billion funding round at a $4.25 billion valuation, and has now re-engaged with Morgan Stanley for a fresh attempt targeting Q2 2026. Bloomberg reported on March 6 that the offering could raise approximately $2 billion.

This stop-start pattern is increasingly common. Companies are treating the IPO as a strategic event, not a financing necessity. Cerebras used its private round to extend runway, then waited for a more favorable public market window. Meanwhile, its shares traded on secondary platforms at approximately $45 per share, reflecting a $10 billion implied valuation -- a meaningful premium over the last primary round.

The education here is about pricing dynamics. The gap between a company's last private round and its secondary market price reflects real-time investor sentiment. When that gap widens significantly, it often signals either that the company has hit key milestones since its last funding or that public-market appetite for the sector is rising. In Cerebras' case, both forces are at work: the AI chip market has expanded rapidly, and the company's technology has attracted meaningful enterprise adoption.

The Mega-Fund Resurgence

The venture capital fundraising landscape in early 2026 looks dramatically different from the discipline-driven austerity of 2023 and 2024. TechCrunch reported on March 11 that General Catalyst is raising $10 billion, Spark Capital is targeting $3 billion, and Founders Fund is closing a $6 billion vehicle. These follow Andreessen Horowitz's $15 billion raise announced in January.

This matters for pre-IPO markets in several concrete ways:

• Larger funds need larger checks. When a fund manages $10 billion, writing $10 million seed checks does not meaningfully deploy capital. These firms will increasingly participate in late-stage rounds and secondary transactions, pushing more capital into pre-IPO companies.
• Dry powder creates price support. PitchBook data shows venture firms ended 2025 sitting on record dry powder. More undeployed capital chasing a finite number of high-quality late-stage companies creates pricing floors that did not exist in the down market of 2022-2023.
• Concentration intensifies. Forbes reported that funds exceeding $500 million now control over half of venture dry powder despite representing a small fraction of fund closures. The capital is concentrating in fewer hands, which means fewer decision-makers are shaping the pricing of late-stage private companies.

For researchers studying market structure, this dynamic is worth watching closely. The concentration of capital in mega-funds has implications for valuation, governance, and the speed at which companies move from private to public.

Secondary Markets Cross the $10 Billion Threshold

According to Caplight's year-end analysis, cumulative secondary trading volume surpassed $10 billion in 2025, supported by larger transaction sizes and broader participation. The Caplight Top 20 Index, which tracks the most actively traded private companies, delivered a 148% return in 2025 -- significantly outperforming the Nasdaq 100.

Seventy companies entered the secondary market for the first time in 2025, with over 100 additional companies showing active investor interest but not yet transacting. This broadening of the tradable universe is one of the most important structural developments in private markets.

A few key dynamics are reshaping secondary market behavior:

• Employee liquidity is driving supply. As IPO timelines extend, employees at late-stage companies face longer holding periods. Secondary sales offer a mechanism to convert paper wealth into cash without waiting for a public listing.
• Institutional buyers are formalizing processes. What was once an ad hoc market with limited price transparency is becoming more structured. Platforms like Forge Global, HIIVE, and others are standardizing price discovery and settlement.
• Mega-companies dominate volume. SpaceX, OpenAI, and Anthropic collectively account for approximately $2.3 trillion in value and contributed 17% of total secondary trading volume in 2025. But the long tail is growing -- and that long tail is where pricing inefficiencies are most pronounced.

The AI IPO Queue Gets Longer

Beyond Cerebras, the queue of AI companies preparing for potential 2026 IPOs is notable for its scale. Anthropic, valued at roughly $380 billion after its latest funding discussions, has engaged Wilson Sonsini to begin IPO preparations, with a listing possible as early as this year. Kalshi prediction markets place the probability at 72%. OpenAI, which raised $40 billion in a single round, is also discussed as a potential 2026 or 2027 candidate.

The concentration of AI companies in the IPO pipeline creates a unique dynamic for secondary markets. When a company like Anthropic is widely expected to go public, secondary pricing begins to reflect public-market-style multiples before the company has actually listed. This compression of the private-to-public pricing gap is a relatively new phenomenon, driven by increased transparency and broader market participation.

For context, the last time this many high-profile technology companies were simultaneously preparing for public listings was 2020-2021. The difference now is that public markets are demanding much higher standards: profitability or a clear path to it, clean governance, and realistic valuations. Companies that meet these criteria -- Cerebras with its differentiated hardware, Anthropic with its enterprise AI contracts -- are likely to price well. Those that do not may find the window narrower than expected.

What 2026 Pricing Discipline Looks Like

One lesson from the 2025 IPO cycle that carries directly into 2026 is the importance of entry price. According to a March 16 analysis from Buy Pre-IPO Stock, the 2025 IPO market rewarded companies that priced conservatively relative to their fundamentals. Strong companies still underperformed if they entered the market at stretched valuations.

This discipline is flowing upstream into private rounds. Late-stage companies face tougher scrutiny on revenue quality, unit economics, cash burn, and customer concentration. EY research suggests managers are accepting 5-10% valuation discounts to complete transactions, acknowledging that liquidity has a price. For secondary market participants, this means pricing flexibility is available -- but only for those who perform thorough due diligence.

The Educational Takeaway

The convergence of Cerebras' IPO preparation, the mega-fund fundraising cycle, and record secondary market volume illustrates a private market ecosystem that is maturing rapidly. Price discovery is improving. Liquidity pathways are diversifying. And the quality bar for public listing is rising.

These are the dynamics we track in our research on pre-IPO markets and venture trends. Understanding how capital formation, secondary pricing, and IPO readiness interact is critical for anyone studying the transition from private to public markets -- whether you are watching Cerebras navigate its second IPO attempt or monitoring how $34 billion in new venture dry powder reshapes late-stage valuations.